The same study revealed that 24% of people ... to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro ...

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

A new drug developed by a mainland Chinese biotechnology company is effective in combating three types of cancer that currently have limited treatment options, according to a multinational study ...

Ohio came in sixth place, seeing an average of 40.8 fatal drug overdose deaths per 100,000 residents each year. This number is 48% above the national average of 27.5, according to the study.

UroGen Pharma shares fell to a 52-week low after a Food and Drug Administration document indicated ... UroGen said on April 26 that updated results from a study of UGN-102 for recurrent low ...

Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or ...

a new study says. More than 14 million poor Medicare beneficiaries receive the Medicare Part D Low-Income Subsidy (LIS), which further reduces their drug costs, researchers said in background notes.

Researchers at the University of California at San Francisco say that using the hallucinogenic drug psilocybin - which ... but this first study went well beyond what we expected,” Dr. Ellen ...

Overall, the study found, ceasing weight loss drugs is likely to yield a more rapid weight regain than ceasing behavioral weight loss measures, like dieting. In total, 7,944 titles and abstracts ...

GLP-1 agonists mimic a hormone called GLP-1, which is released from the gastrointestinal system after eating, according to study co-author ... started the weight-loss drugs, they self-reported ...